Pellino1 regulates neuropathic pain as well as microglial activation through the regulation of MAPK/NF-κB signaling in the spinal cord

Lijuan Wang, Yin Cui, Tianya Liu, Abdul Mannan, Yan Zhou, Jun‐Li Cao, Lu ChenJournal of Neuroinflammation 2020 · DOI

TL;DR

This study identifies Pellino1 (Peli1) as a key regulator of neuropathic pain by demonstrating its crucial role in microglial activation within the spinal cord. By modulating MAPK/NF-κB signaling and promoting pro-inflammatory cytokine release, Peli1 contributes to the development and maintenance of pain, suggesting it as a potential therapeutic target.

What Problem Does This Paper Address?

Neuropathic pain, a debilitating condition arising from nerve damage, is notoriously difficult to treat. While spinal cord microglia are known to be central players in its development, the precise molecular mechanisms driving their activation remain incompletely understood. This paper aims to elucidate the role of Pellino1 (Peli1), an E3 ubiquitin ligase, in this process, specifically investigating its contribution to microglial activation and subsequent pain hypersensitivity.

Methods

The researchers employed a multi-pronged approach using a mouse model of chronic constriction injury (CCI) of the sciatic nerve to induce neuropathic pain. Key techniques included:

  • Behavioral Assays: Thermal hyperalgesia and mechanical allodynia were measured using Hargreaves apparatus and von Frey hairs, respectively, to assess pain sensitivity.
  • Molecular Biology Techniques:
    • qPCR: To quantify mRNA levels of Peli1 and various inflammatory markers (e.g., Iba1, CD11b, TNF-α, IL-6, IL-1β).
  • Western Blot: To measure protein levels and phosphorylation states of key signaling molecules (e.g., Peli1, p-ERK, p-p38, p-JNK, p-NF-κB p65, p-Akt).
  • Immunofluorescence: To visualize the cellular localization of Peli1 and other markers (e.g., Iba1 for microglia, NeuN for neurons, GFAP for astrocytes) and assess their co-localization.
  • In Vitro Studies: BV2 microglial cells were used to investigate the direct effects of Peli1 on microglial activation and inflammatory responses to lipopolysaccharide (LPS).
  • Immunoprecipitation: To examine the ubiquitination status of TRAF6, a crucial signaling adaptor.
  • Genetic Manipulation: Lentiviral shRNA and siRNA were used to knockdown Peli1 expression both in vivo and in vitro.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from animal models and cell cultures.

Key Insights and Ideas

  • Peli1 as a Microglial "Hotspot": The study strongly implicates Peli1 as a key player in microglial activation, with its expression significantly increasing in microglia within the spinal cord following nerve injury. This suggests that Peli1 might act as a direct trigger or amplifier of microglial responses in neuropathic pain.
  • The MAPK/NF-κB Axis is Central: Peli1's influence on neuropathic pain appears to be mediated through the well-established MAPK and NF-κB signaling pathways. The findings highlight how Peli1's upregulation leads to increased phosphorylation of ERK, p38, and JNK, and activation of NF-κB, which are known drivers of neuroinflammation.
  • TRAF6 Ubiquitination as a Mechanism: The research provides evidence that Peli1 facilitates K63-linked ubiquitination of TRAF6. This is a significant mechanistic insight, as TRAF6 is a critical scaffold protein that bridges upstream signaling events to the activation of both MAPK and NF-κB pathways.
  • Beyond Microglia? While Peli1 is predominantly found in microglia, the study acknowledges its presence, albeit at lower levels, in neurons and astrocytes, leaving open the possibility of broader roles in the neuropathic pain cascade.

Key Results

  • Peli1 Upregulation: CCI significantly increased Peli1 mRNA and protein levels in the ipsilateral spinal cord, peaking at 3-7 days post-injury.
  • Pain Behavior Modulation: Knockdown of Peli1 using shRNA or siRNA significantly alleviated both thermal hyperalgesia and mechanical allodynia, indicating Peli1's essential role in pain induction and maintenance.
  • Inhibition of Glial Activation: Peli1 knockdown suppressed CCI-induced activation of microglia (indicated by Iba1 and CD11b expression) and astrocytes (indicated by GFAP expression).
  • Reduced Pro-inflammatory Cytokines: Peli1 inhibition significantly reduced the production of TNF-α, IL-6, and IL-1β in the spinal cord after CCI and in LPS-stimulated BV2 microglial cells.
  • MAPK/NF-κB Pathway Attenuation: Peli1 knockdown markedly decreased the phosphorylation of ERK, p38, and JNK, as well as the activation of NF-κB p65, in the spinal cord following CCI.
  • TRAF6 Ubiquitination Reduction: Peli1 knockdown significantly reduced K63-linked ubiquitination of TRAF6 in the ipsilateral spinal cord after CCI.
  • Microglial Polarization and Migration: In vitro, Peli1 inhibition prevented LPS-induced M1 microglial polarization and reduced microglial migration.

Limitations and Future Work

  • Cell-Specific Roles: While Peli1 is primarily found in microglia, its presence in neurons and astrocytes is acknowledged. The authors suggest that future research should employ cell-specific approaches to precisely delineate the contribution of Peli1 in each cell type to neuropathic pain.
  • siRNA Degradation: The study notes that siRNA knockdown might not be as effective as shRNA due to potential cytoplasmic degradation, which could explain the partial reversal of established pain behaviors observed with siRNA.
  • Therapeutic Potential: The findings strongly suggest Peli1 as a promising therapeutic target for neuropathic pain. Future work could focus on developing specific Peli1 inhibitors or modulators for clinical application. Further investigation into the precise mechanisms by which Peli1 mediates TRAF6 ubiquitination in different pathological states is also warranted.

Summary updated

Abstract

Abstract Background Spinal cord microglia plays a crucial role in the pathogenesis of neuropathic pain. However, the mechanisms underlying spinal microglial activation during neuropathic pain remain incompletely determined. Here, we investigated the role of Pellino1 (Peli1) and its interplay with spinal microglial activation in neuropathic pain. Methods In this study, we examined the effects of Peli1 on pain hypersensitivity and spinal microglial activation after chronic constriction injury (CCI) of the sciatic nerve in mice. The molecular mechanisms involved in Peli1-mediated hyperalgesia were determined by western blot, immunofluorescence, quantitative polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay (ELISA). We utilized immunoprecipitation to examine the ubiquitination of tumor necrosis factor receptor-associated factor 6 (TRAF6) following CCI. In addition, we explored the effect of Peli1 on BV2 microglial cells in response to lipopolysaccharide (LPS) challenge. Results We found that CCI induced a significant increase in the levels of Peli1, which was present in the great majority of microglia in the spinal dorsal horn. Our results showed that spinal Peli1 contributed to the induction and maintenance of CCI-induced neuropathic pain. The biochemical data revealed that CCI-induced Peli1 in the spinal cord significantly increased mitogen-activated protein kinase (MAPK) phosphorylation, activated nuclear factor kappa B (NF-κB), and enhanced the production of proinflammatory cytokines, accompanied by spinal microglial activation. Peli1 additionally was able to promote K63-linked ubiquitination of TRAF6 in the ipsilateral spinal cord following CCI. Furthermore, we demonstrated that Peli1 in microglial cells significantly enhanced inflammatory reactions after LPS treatment. Conclusion These results suggest that the upregulation of spinal Peli1 is essential for the pathogenesis of neuropathic pain via Peli1-dependent mobilization of spinal cord microglia, activation of MAPK/NF-κB signaling, and production of proinflammatory cytokines. Modulation of Peli1 may serve as a potential approach for the treatment of neuropathic pain.
BibTeX
@article{wang2020pellino,
  author = {Lijuan Wang and Yin Cui and Tianya Liu and Abdul Mannan and Yan Zhou and Jun‐Li Cao and Lu Chen},
  title = {{Pellino1 regulates neuropathic pain as well as microglial activation through the regulation of MAPK/NF-κB signaling in the spinal cord}},
  journal = {Journal of Neuroinflammation},
  year = {2020},
  doi = {10.1186/s12974-020-01754-z},
}
Figure